Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics Files $20M Shelf Registration

NEW YORK (GenomeWeb) – Response Genetics has filed a shelf registration with the US Securities and Exchange Commission to offer up to $20 million in securities from time to time.

Securities that may be offered include Response's common stock, preferred stock, and warrants, the company said in its SEC document. Proceeds from any offering will go toward general corporate purposes, such as the funding of its operations, working capital, R&D efforts, capital expenditures, and strategic investments.

In December, Response launched a $4.8 million public offering of its common stock.

Late last month, the Los Angeles-based molecular diagnostics firm said that it received a warning letter from the Nasdaq that its shares had closed below a minimum $1 per share for 30 consecutive business day, putting Response in jeopardy of having its stock delisted from the Nasdaq Capital Market. The firm has until Dec. 17 to regain compliance.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.